Top of the Street: Sandoz, Bureau Veritas, SSAB
05/05/2026 14:02
A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Barclays upgrades Swiss generic and biosimilar drugmaker Sandoz SDZ.S to "overweight" from "equal weight", citing a strong pipeline of upcoming products and an attractive valuation ** RBC raises French business services provider Bureau Veritas BVI.PA to "sector perform" from "underperform", saying strategic developments at peer Intertek ITRK.L could underscore valuation support across the sector while the stock's recent underperformance limits downside risk ** Morgan Stanley ups Swedish steelmaker SSAB SSABa.ST to "overweight" from "equal weight" (*Analyst rankings from Thomson Reuters StarMine. The scale is from 1-star to 5-star with 5 being the best. Analysts are ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.) (Reporting by Marta Frackowiak and Leo Marchandon) ((marta.frackowiak@thomsonreuters.com; leo.marchandon@thomsonreuters.com ))